Recombinant Human Interferon α2b Vaginal Effervescent Capsules in the treatment of patients with HPV infection: a Meta-analysis
ZHANG Shudan1 LI Qi2 LI Ge3
1.Department of Pharmacy, Dalian Hospital of Traditional Chinese Medicine, Liaoning Province, Dalian 116013, China;
2.Department of Internal Medicine, the Third Hospital of Wafangdian, Liaoning Province, Wafangdian 116300, China;
3.Department of Oncology, Dalian Hospital of Traditional Chinese Medicine, Liaoning Province, Dalian 116013, China
Abstract:Objective To review systematically the curative effect and safety of Recombinant Human Interferon α2b Vaginal Effervescent Capsules (Xinfuning) on HPV infection, and provide clinicians with an evidence base for their clinical decision making. Methods The databases of PubMed, EMbase, Cochrane Library, CBM, Wanfang, CNKI and VIP were retrieved for collecting RCT and CCT about the treatment of HPV infection with Xinfuning before May 2017, and reference lists were also searched. According to the inclusion and exclusion criteria, two reviewers screened and assessed the potential studies independently, and then the data was extracted. The data was given a Meta-analysis by using RevMan 5.3 software. Results Twenty-three study articles were included, involving 3442 patients. After 3 months, the test results showed that the clinical curative effect of Xinfuning treatment group in treating human papilloma virus was better than that of control group (OR = 11.67, 95%CI: 5.50-24.75, P < 0.000 01). After 6 months, the test results showed that the clinical curative effect of Xinfuning treatment group in treating human papilloma virus was better than that of control group (OR = 2.03, 95%CI: 1.41-2.92, P = 0.0001). After 12 months, the test results showed no significant differences of clinical curative effect between Xinfuning treatment group and the control group (OR = 1.24, 95%CI: 0.85-1.81, P = 0.26). There were no obvious adverse reactions in the two groups. Conclusion Xinfuning has significant curative effect in treating HPV infection, and the safety is good.
张树丹1 李琪2 李戈3. 重组人干扰素α2b阴道泡腾胶囊治疗HPV感染的Meta分析[J]. 中国医药导报, 2017, 14(31): 111-115.
ZHANG Shudan1 LI Qi2 LI Ge3. Recombinant Human Interferon α2b Vaginal Effervescent Capsules in the treatment of patients with HPV infection: a Meta-analysis. 中国医药导报, 2017, 14(31): 111-115.